Play all

Intro

Lung Cancer Incidence and deaths

Lung Cancer Histology

Lung Cancer Presenting symptoms

Lung Cancer Risk factors

Lung Cancer When to initiate work-up

Lung Cancer TNM Staging

Lung Cancer Staging

Lung Cancer Mediastinal staging

Lung Cancer Surgery

Lung Cancer Surgical outcomes

Radiofrequency ablation of lung tumors

Lung Cancer Subtypes

Advanced NSCLC. Stage IV

NSCLC Chemo approaches by histology

Targeting specific mutations

Small molecule inhibitors treat specific proteins

Receptors and specific inhibitors

IPASS: response rates by mutation status

Incidence of Single Driver Mutations

Clinical Responses and Resistance

Molecular Basis of Resistance

Immunotherapy

Immune Checkpoint inhibition

PD1 Inhibitor in NSCLC

Description:

Explore the latest surgical and nonsurgical treatments for lung cancer in this informative UCLA MDChat featuring cardiothoracic surgeon Dr. Jay Lee and hematologist/oncologist Dr. Jonathan Goldman. Gain insights into lung cancer staging and its crucial role in treatment planning. Delve into topics such as lung cancer incidence, histology, risk factors, and diagnostic work-up. Learn about TNM staging, surgical options, and outcomes. Discover advanced treatments like radiofrequency ablation and targeted therapies for specific mutations. Understand the molecular basis of resistance and the potential of immunotherapy, including immune checkpoint inhibition and PD1 inhibitors in non-small cell lung cancer (NSCLC).

Treatment for Lung Cancer - Jay Lee, MD and Jonathan Goldman, MD - UCLAMDChat

University of California, Los Angeles

Add to list

#Health & Medicine #Health Care #Oncology #Chemotherapy #Cancer Treatment #Targeted Therapy #Immunotherapy

0:00 / 0:00